The global organ preservation market size was valued at USD 308.32 million in 2025 and is projected to grow from USD 324.66 million in 2026 to USD 490.74 million by 2034 at a CAGR of 5.3% during the forecast period 2026-2034. North America dominated the global organ preservation market, accounting for 39.2% of the total market share in 2025
Organ preservation refers to the techniques and processes used to maintain the viability and function of organs outside the body for transplantation purposes. It is a critical component of organ transplantation, ensuring that organs remain in optimal condition during the time between donation and transplantation. Various methods of preservation, such as cold storage, hypothermic perfusion, and machine perfusion, help slow down metabolic processes, reduce cell damage, and extend the time an organ can be safely stored.
Download a Free Sample To learn more about this report,
Advancements in Normothermic Machine Perfusion (NMP) Technique
The adoption of NMP as an alternative to traditional cold storage is becoming a key trend in the global organ preservation market. Recent innovations in normothermic machine perfusion (NMP) are significantly improving organ viability, extending preservation times, and increasing transplant success rates. The ongoing collaboration between key industry players is driving technological advancements in this field.
By simulating physiological conditions, NMP enhances organ viability, improves transplant outcomes, and extends the donor pool, reshaping the future of transplantation.
Shift towards Vitrification and Nanowarming
The shift toward vitrification and nanowarming for long-term organ cryopreservation is gaining momentum as the demand for extended storage, improved logistics, and fewer geographical & time constraints in transplantation increases. This innovative method enhances organ viability, expands donor availability, and improves overall transplant efficiency.
The adoption of vitrification and nanowarming as a revolutionary trend is paving the way for longer organ storage times, reducing the urgency of immediate transplantation, and significantly improving patient outcomes.
Rising Prevalence of Organ Failure
The increasing incidence of organ failure is driving the demand for advanced organ preservation and transplantation technologies to enhance viability, storage, and transplant success rates. The rising burden of chronic diseases, traumatic injuries, and multi-organ failure (MOF) further underscores the need for improved preservation methods.
Thus, as the prevalence of organ failure continues to rise, the demand for innovative preservation solutions is expected to grow, driving market expansion and improving patient survival rates.
Increasing Funding for Advanced Organ Preservation Methods
Growing investments in organ preservation technologies are a key driver of market growth, facilitating research advancements, regulatory approvals, and healthcare infrastructure development. Financial backing from both private investors and government bodies is accelerating innovation and commercialization in this sector.
This surge in funding is fueling the development of next-generation preservation technologies, improving transplant success rates, and contributing to the overall expansion of the market for organ preservation.
Shortage of Organ Donors
The widening gap between organ demand and supply remains a major challenge in organ transplantation. Despite medical advancements, the number of patients requiring transplants far exceeds the availability of viable donor organs. Low donor registration rates, stringent eligibility criteria, and organ wastage due to preservation limitations further exacerbate this shortage. Moreover, geographic disparities and transportation challenges hinder timely delivery, reducing transplant success rates and increasing mortality on waiting lists. These constraints not only limit access to life-saving transplants but also restrain market growth, highlighting the urgent need for improved donor programs.
Strategic Partnerships and Collaborations
Collaborations between organ banks, healthcare institutions, and biotechnology companies are fostering advancements in organ preservation technology. These partnerships drive innovation, expand the availability of viable organs, and enhance transplant success rates, creating significant growth opportunities for the market.
Such strategic alliances are paving the way for cutting-edge preservation techniques, accelerating market growth, and addressing the growing demand for life-saving organ transplants.
High Cost and Limited Accessibility of Advanced Organ Preservation Technologies
The high cost of advanced organ preservation systems, including normothermic machine perfusion (NMP), hypothermic oxygenated perfusion (HOPE), and ex vivo perfusion devices, remains a significant challenge for the organ preservation market. These technologies require substantial capital investment, specialized consumables, trained personnel, and dedicated infrastructure, making their adoption difficult for small hospitals and transplant centers, particularly in low- and middle-income countries. In addition, maintenance costs, reimbursement limitations, and complex regulatory requirements further hinder widespread implementation.
As healthcare providers continue to balance clinical benefits with financial constraints, reducing technology costs, expanding reimbursement coverage, and improving infrastructure will remain critical challenges for the long-term organ preservation market growth.
Request Customizationto receive a tailored report.
University of Wisconsin (UW) Solution Dominated the Market with 42.3% Share in 2025
The University of Wisconsin (UW) solution segment accounted for the largest share of the global organ preservation market at 42.3% in 2025, driven by its proven effectiveness in preserving abdominal organs, widespread clinical acceptance, and extensive use in kidney, liver, and pancreas transplantation procedures. Its ability to minimize ischemic injury and improve transplant outcomes has reinforced its leading market position.
Lung is Expected to be the Fastest-Growing Segment with a CAGR of 8.7%
The lung segment is anticipated to witness the fastest growth, registering a CAGR of 8.7% during 2026–2034, fueled by the increasing prevalence of end-stage pulmonary diseases, rising lung transplant procedures, and advancements in ex vivo lung perfusion (EVLP) technologies that improve donor organ utilization and transplantation success rates.
Static Cold Storage Dominated the Market with 56.2% Share in 2025
The static cold storage segment held the largest market share of 56.2% in 2025, owing to its cost-effectiveness, ease of implementation, and widespread adoption as the standard preservation technique for solid organ transplantation. Its reliability in maintaining organ viability during transport continues to support its dominance across transplant centers worldwide.
Speak to an Analystto discuss market opportunities.
North America dominated the global organ preservation market with a 39.2% market share, valued at USD 120.86 million in 2025. The region's leadership is supported by a well-established transplant infrastructure, increasing organ donation and transplantation procedures, favorable reimbursement frameworks, and widespread adoption of advanced organ preservation technologies, including machine perfusion systems. Continuous investments in transplant research and healthcare innovation further strengthen market growth.
The United States accounted for an estimated USD 106.36 million of the market in 2025, making it the largest contributor in North America. Market growth is driven by the rising number of organ transplant procedures, strong presence of leading organ preservation technology providers, increasing adoption of normothermic and hypothermic machine perfusion systems, and significant government and institutional funding for transplant research.
Canada generated an estimated USD 14.50 million in 2025. Growing investments in transplant infrastructure, increasing awareness of organ donation, expanding adoption of advanced preservation technologies, and supportive public healthcare initiatives are contributing to the country's market growth.
Europe accounted for 28.1% of the global organ preservation market share, reaching USD 86.64 million in 2025. The regional market is supported by robust public healthcare systems, increasing organ transplantation activities, favorable regulatory frameworks, and ongoing investments in research related to machine perfusion and organ preservation technologies. Collaborative initiatives among European transplant networks further enhance organ utilization rates.
Germany led the European market with an estimated value of USD 18.19 million in 2025. The country's advanced healthcare infrastructure, high transplant volumes, strong medical device manufacturing sector, and continuous investment in clinical research are driving the adoption of innovative organ preservation solutions.
The United Kingdom represented an estimated USD 13.86 million in 2025. Growth is supported by NHS investments in transplantation services, increasing organ donation awareness campaigns, expanding use of ex vivo organ perfusion technologies, and ongoing research to improve transplant outcomes.
Asia Pacific accounted for 22.4% of the global organ preservation market, valued at USD 69.06 million in 2025, and is projected to register the fastest CAGR of 9.3% during the forecast period. Rising healthcare expenditure, growing incidence of end-stage organ diseases, expanding transplant infrastructure, and increasing government initiatives to strengthen organ donation programs are accelerating regional market growth.
China accounted for an estimated USD 29.01 million in 2025, making it the largest market in Asia Pacific. Market growth is driven by healthcare reforms, increasing investments in transplant centers, expansion of organ donation programs, and growing adoption of advanced organ preservation and machine perfusion technologies.
Japan generated an estimated USD 15.19 million in 2025. The country's aging population, increasing prevalence of chronic kidney and liver diseases, technological advancements in transplantation, and strong focus on clinical innovation continue to support demand for organ preservation solutions.
The Middle East & Africa accounted for 4.2% of the global organ preservation market, totaling USD 12.95 million in 2025. Market growth is supported by expanding healthcare infrastructure, increasing investments in organ transplant programs, improving access to specialized healthcare services, and rising awareness regarding organ donation across the region.
The United Arab Emirates (UAE) accounted for an estimated USD 3.24 million in 2025. The country's market is driven by investments in advanced healthcare infrastructure, establishment of specialized transplant centers, government initiatives to promote organ donation, and increasing adoption of innovative organ preservation technologies.
Africa is witnessing gradual growth in the organ preservation market, supported by improving healthcare infrastructure, increasing awareness of organ donation, and expanding transplant capabilities. Countries such as South Africa, Kenya, and Egypt are investing in transplant programs and healthcare modernization, creating long-term opportunities for manufacturers of organ preservation solutions.
Unlock Regional Insightsto access country-level data, & regional trends.
Key market players are actively adopting various business strategies to strengthen their position and drive market growth. These strategies include strategic collaborations, acquisitions, awareness programs, government initiatives, and product approvals and launches. By forming alliances with healthcare institutions, biotechnology firms, and research organizations, companies aim to accelerate innovation and expand their market reach.
Getinge is a Swedish medical technology company with expertise in healthcare and life sciences solutions. It offers products and services for intensive care, cardiovascular procedures, operating rooms, sterile processing, and life sciences. Moreover, the company specializes in enhancing clinical outcomes, optimizing hospital workflows, and improving patient care with cutting-edge medical technologies.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com